Roche transforms healthcare with AI innovation, enhancing patient care and accessibility

FF. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide through two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company's headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world in terms of revenue and the leading provider of cancer treatments globally.

‍

Revolutionizing Healthcare

Roche has joined forces with DeepBrain to use AI technology to revolutionize patient care and accessibility to medical information. This partnership aims to pioneer a new era characterized by enhanced healthcare accessibility, efficiency, and patient-centricity. They plan to achieve this by introducing AI doctors and real-time mobile medical services, which have the transformative power to reshape how medical services are delivered and experienced.

‍

‍

Pioneering the Future

The partnership between Roche and DeepBrain is revolutionizing patient care and accessibility by introducing AI doctors and real-time mobile medical services. By combining Roche's expertise in pharmaceuticals and DeepBrain's proficiency in AI, this collaboration has the transformative power to reshape how medical services are delivered and experienced, resulting in enhanced healthcare accessibility, efficiency, and patient-centricity.